Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FKJG5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,397
Award facts
- Contract value 100% obligated
- $12,396.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60 count). This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, was awarded without a set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group Inc. operates as the prime contractor with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award contract valued at $499,999,999 established on November 13, 2025, and extending through December 31, 2036. The PPV-G GEN V program represents part of the DLA's $30.3 billion pharmaceutical acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The vendor's registration with the System for Award Management since 2001 and demonstrated performance across numerous delivery orders positioning it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FKJG5?
SPE2DR26FKJG5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FKJG5 worth?
The government has obligated $12,397 on SPE2DR26FKJG5.
Is contract SPE2DR26FKJG5 an order under another contract?
Yes. SPE2DR26FKJG5 is a delivery order under SPE2DR25D9105, an indefinite delivery contract.
Was contract SPE2DR26FKJG5 competed?
The extent of competition for SPE2DR26FKJG5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award